Dr. Jun Okuda and Dr. Jochen Büchs of the RWTH Aachen University each received the honorary doctorate for excellent work in research and teaching at the Osaka University in Japan.
Dr. Jun Okuda and Dr. Jochen Büchs of the RWTH Aachen University each received the honorary doctorate for excellent work in research and teaching at the Osaka University in Japan.
Within the framework of “Exzellenzstrategie” of the Government and the Lands the Forschungszentrum Jülich participates in four excellence clusters und functions as a partner of the respective universities.These are the following excellence clusters: “CEPLAS Cluster of Excellence on Plant Sciences – SMART plants for the demands of tomorrow” with the Heinrich-Heine Universität Düsseldorf and University […]
The Transfer- und Gründerzentrum (TGZ) of the RWTH Aachen University honors enterprise start-ups out of universities for the third time this year with the Spin-off Award. Within the framework of the annual Aachen Technology and Entrepreneurship Conference (atec) on November 30th 2018 the awarding takes place by Prof. Malte Brettel, vice-rector of economy and industry […]
The Aachen-based startup Protembis GmbH receives $ 10 Million capital requirements especially with the participation of Seed Fonds III for the region of Aachen and Mönchengladbach GmbH & Co. KG and Abiomed Inc. With this, the company wants to develop its „ProtEmbo“ technology for the minimization of the risk of stroke in the case of heart valve intervention to market maturity.
After 2012 and 2013 the pharmaceutical company Grünenthal is again selected as one of the best employers in Europe. Due to its successes in the countries Italy, Portugal and Spain, Grünenthal impressed the jury with its positive business culture.
Peter Linder and Dr. Matthias Großmann of the spin-off innoVitro GmbH won the AC²-Gründerwettbewerb (founders cempetition) with their innovative method of analysis to examine agents on artificially generated myocardial tissue. The method based on the “CellDrum” technology renders animal testing increasingly redundant.
After three years of construction, the Center for Biohybrid Medical Systems (CBMS) invited its friends and partners to a ceremonial symposium. Within the CBMS researchers from different disciplines collaborate to jointly develop biohybrid medical systems.
Philip Just Larsen was appointed as the Chief Scientific Officer by the Aachen family company Grünenthal. Since 1st July, 2018 the internist and neurologist by training Larsen is the head of the research and development organisation. Hence, he succeeds the former director of research Dr. Klaus-Dieter Langner who leaves the enterprise after 20 years.
Hemovent GmbH commenced the GLP in vivo long-term use of its ECMO system for the support of lung and heart dysfunctions.
The first cross-boarder BusinessTreff of MedLife e.V. with the involvement of the Dutch partner LifetecZONe granted the participants an insight into the latest research and progress.